BRCA2 and breast carcinoma: The number of BRCA1 and BRCA2 mutations predicted by BOADICEA when the 'full pedigrees' were considered was close to the observed number in each subcategory except among families with four or more breast cancer cases, for which the number of predicted BRCA1 mutation was higher than the number observed (6.20 versus 2).